Objectives: Fetal growth and rapid postnatal weight gain are associated with adverse respiratory outcomes in childhood. However, the preterm-born population is less well studied. We assessed if the increased respiratory symptoms associated with altered fetal growth and infant weight gain were mediated by early factors.
adulthood potentially developing into early-onset chronic obstructive pulmonary disease. 1, 4 Recently there has been interest in both antenatal and postnatal growth patterns in children, and how these relate to risk of childhood respiratory disease. Historically, birthweight has been used a proxy for fetal wellbeing; however, it is recognized that satisfactory birth weight results from months of development during which the fetus may be exposed to adverse intrauterine condition. 5, 6 Adaptation to this adversity affects the development of organ systems, 7 such as the respiratory system, which continues to develop throughout gestation. 8 Dysregulation of lung growth may be further compounded by preterm birth 9 and pulmonary inflammation associated with neonatal respiratory distress. 10 To date, the few studies investigating the association of fetal growth patterns with later childhood respiratory disease have reported inconsistent results. [11] [12] [13] [14] Early infant growth is also linked to increased respiratory sequelae in childhood. However, studies have focused largely on term-born populations. [15] [16] [17] [18] [19] A recent meta-analysis of 147 000 children including 7384 preterm-born individuals noted an association between greater weight gain in the first year of life and increased childhood asthma. 20 Further exploration of 24 938 children (2053 born preterm) noted an association between gestational age, infant weight gain, and measures of lung function. 21 However, both studies included preterm-born subjects who were recruited in largely term-born cohorts, thus suggesting selection bias. Moreover, previous studies have reported only associations and have not explored the important early life factors that may influence the effect of fetal growth trajectories and postnatal weight gain on respiratory outcomes.
In this study, we investigated the association of fetal growth parameters and postnatal weight gain with the risk of respiratory symptoms in a cohort of preterm-born children. Furthermore, we conducted multiple regression analyses and mediation analyses to identify early-life factors that may account for the association between fetal or infant weight gain and childhood respiratory symptoms. We hypothesized that change in fetal growth trajectory, or rapid postnatal weight gain in infancy, would be associated with increased childhood respiratory symptoms in preterm-born children. 24 and that of others as it represents specific stages in lung development and children most at risk of lung disease. Intrauterine growth restriction (IUGR) was defined as <10th centile for standardized birthweight corrected for gestation and gender using the LMS method (Medical Research Council, UK). 25 
| Fetal growth data
Antenatal scans were obtained through NWIS for four of seven health boards in Wales who share a common radiology record system. Crown rump length (CRL), head circumference (HC), and femur length (FL)
were extracted using a method coded in C++ and checked for accuracy against the original data. Multiple pregnancies were excluded as identity of which fetus was scanned at 1st and 2nd trimesters was uncertain.
Gestation (in completed weeks) was abstracted from the scan reports where possible, or, if missing, was calculated from the difference between gestation at birth and scan date. Robinson (CRL) and Chitty (HC and FL) growth charts were used to create z-scores, adjusted for gestational age and gender at the time of measurement, using the published equations. 
| Infant weight data
Postnatal weight data were provided by NWIS. The weight closest to 9 months of age (limited to 6-12 months) was used to derive z-scores using the LMS method, as above. Participants with birthweight or postnatal weight outside ±3.5 SD of the mean, or with unknown gestational age were excluded.
Infant weight gain between birth and 9 months of age was defined by dichotomizing the population in to those who demonstrated an increase of >0.67 SD in weight and those who did not, as previously. 25 We also used the method of Royston to calculate measures of conditional weight velocity between birth and nine months of age. 28 
| Respiratory outcome data
Respiratory outcomes were extracted from the RANOPS questionnaires which included wheeze-ever, recent wheeze (last 3 months for <5 years of age; last 12 months for ≥5 years of age), use of inhalers, hospital admissions for chest-related problems, and doctor-diagnosed asthma (≥5 years of age only). All outcomes were dichotomous. 2 Rates of maternal smoking during pregnancy and current smoking were also taken from the RANOPS questionnaire.
| STATISTICAL ANALYSIS
Chi-squared tests were used to investigate the differences in categorical demographic data between datasets used in the fetal growth analysis, and between weight gain groups (>0.67 SD weight gain or not) in the infant growth analyses. Normality of continuous data was checked by visually inspecting Q-Q plots. Independent sample t-tests were used for normally distributed continuous variables. WIMD score was subsequently converted in to quintiles for use in statistical models.
Since every case in the fetal analysis did not have a complete set of biometric data, we used sub-sets of cases with the appropriate combination of measurements (eg, CRL and HC). To assess whether this approach would introduce any bias, we compared the baseline demographics of each sub-set against the reference set (before exclusion for missing biometric data) using standardized differences. Then, univariate logistic regression models were used to investigate the association between fetal size in the first trimester (CRL) and size in the 2nd trimester (HC and FL) with childhood respiratory outcomes. Further models then investigated change in growth between 1st trimester and birth (CRL-Birthweight), between 2nd trimester and birth (HC-Birthweight and FL-birthweight), and odds of childhood respiratory outcomes. "No change" was set as the reference category. Confounders were then included in adjusted multivariable models if they had a Pvalue <0.10 for association with "wheeze-ever," which was the considered the primary outcome for all analyses. A similar modeling approach was applied to the infant weight gain data, using both weight gain >0.67 SD (or not) then conditional weight gain as the primary exposure variables.
Next, we considered the whole cohort population (including preterm and term groups) and used interaction terms to investigate the combined effects of gestation groups and infant weight gain when defined as >0.67 SD change between birthweight and weight at 9 months. Term-born children with "no change" for weight gain were used as the control category. Both univariate, and multivariable modeling including covariates with a P-value <0.10, were performed.
All modeling was performed using SPSS (version 20, IBM, Chicago IL).
P < 0.05 was considered statistically significant.
Finally, to assess if the relationship between weight gain and "wheeze-ever" was mediated through gestational age and other significant covariates, we performed mediation analysis using structural equation modeling (Mplus version 7, Muthen and Muthen, Los Angeles, CA); all potential mediators were entered in parallel. Figure S1) . When compared to the whole dataset, there were small differences (standardized differences <0.10) in demographics when alternative fetal measurements were used in the analysis (Supplementary Table S1 ).
For first trimester CRL size at 12 weeks' and 2nd trimester HC or FL at 20 weeks' gestation, association with childhood respiratory outcomes were negligible (Supplementary Table S2 ).
Gestational age, gender, ethnicity, current maternal smoking, family history of asthma/atopy, breastfeeding, WIMD, and whether the child was aged over or under 5 years were all statistically significantly associated with wheeze-ever in univariate analysis (Supplementary Table S3 
| Infant weight gain
Following exclusions for missing birthweight, missing weight at 9 months, and weight z-score ±3.5 SD, 5824/7149 (81%) of responders to the questionnaire survey had valid data; 3425 participants were born preterm and 2399 were born at term (Supplementary Figure S1) .
Demographics of preterm-born children with, and without weight gain of >0.67 SD are presented in Supplementary Table S4 . Children of lower birthweight, whose mothers smoked during pregnancy, of lowest WIMD quintile, and whose mothers currently smoke, were more likely to exhibit weight gain >0.67 SD between birth and 9 months of age.
Children born with IUGR, delivered by caesarean section, and as one of multiple birth were also more likely to exhibit weight gain.
In univariate analysis, increased wheeze-ever was associated with infant weight gain (OR1.20; 95%CI 1.03, 1.41), lower gestational age, male gender, maternal smoking in pregnancy, current maternal smoking, family history of asthma/atopy, and lower WIMD quintile. Non-white ethnicity, breastfeeding and being ≥5 years of age were associated with decreased odds of wheeze-ever (Supplementary Table S5 ). In the adjusted model, an increase in weight >0.67 SD between birth and 9 months of age was associated with wheeze-ever in preterm-born children (OR 1.22; 95%CI
1.02, 1.45) ( Table 2 ). All other covariates remained significant aside from breastfeeding and maternal smoking in pregnancy. Excluding children from multiple births did not affect the results (data not shown). When the cohort was stratified in to those aged <5 years and those aged ≥5 years, wheeze-ever was significant in the fully adjusted model in ≥5 years age group only (OR 1.37; 95%CI 1.06, 1.77), Table 2 . Sensitivity analysis using conditional growth showed similar results, with marginally attenuated ORs (Supplementary Table S6 ).
Compared to term-born children who did not demonstrate weight gain of >0.67 SD between birth and the age of 9 months, children born ≤32 weeks' gestation with infant weight gain of >0.67 SD had increased odds of wheeze-ever (OR 5.04; 95%CI 3.36, 7.54, Figure 1) .
Results of the mediation analysis are summarized in Figure 2 .
Gestational age, maternal smoking in pregnancy, current maternal smoking, and breastfeeding all had statistically significant univariate associations with weight gain; the test for association was inconclusive 
| DISCUSSION
In our cohort of preterm-born children, we have reported that rapid weight gain in the first year of life is statistically significantly associated with increased wheeze in childhood. We also noted the interaction between birth at the extremes of prematurity and postnatal weight gain resulted in the poorest respiratory outcome (OR 5.04). Using mediation analysis, we have identified modifiable factors that may have an important influence on the relationship between weight gain and childhood respiratory symptoms. We also reported increased odds for wheeze-ever for fetal growth deceleration between the 1st-2nd trimester (OR 1.59), and for growth acceleration between the 2nd trimester and birth (OR 1.60).
| Fetal growth
Previous studies in term-born cohorts have used birthweight as proxy for fetal growth and examined associations with respiratory outcomes, with mixed results. 29, 30 By assessing growth over gestational ranges,
we have attempted to investigate the impact of growth trajectory in preterm-born children during key periods of development. Three groups have investigated similar hypotheses to ours, all of which were conducted in term-born cohorts. In common with our study, the Generation-R cohort did not detect any association between fetal size and childhood respiratory outcomes in early childhood. 14 In contrast, Turner and colleagues reported decreased odds for respiratory symptoms and improved lung function per millimeter increase in fetal measurement in term-born children at 5 and 10 years of age.
12,13
The mechanisms of how change in growth rate impacts upon the developing organs are not yet known, however, the main structures of the respiratory system are established by the early second trimester, whereas differentiation and maturation occur between the 2nd trimester and birth. 31 One possibility is that structural deficits established early in gestation manifest later as airway obstruction due to smaller airways. For example, growth faltering between the 1st and 2nd trimesters was statistically significantly associated with increased respiratory symptoms in the Aberdeen cohort. 32 Our results also noted that growth deceleration between the 1st and 2nd trimester was associated with increased odds of wheeze-ever (OR 1.59 95%CI 1.01, 2.51). An interesting finding within the Southampton cohort was that growth faltering between the 1st and 2nd trimester was also linked to non-atopic wheeze, whereas faltering between second to third trimesters was statistically significantly associated with atopic wheeze. 11 The authors speculate this may relate to altered immunological status. To date, the RANOPS cohort does not have any direct data on atopic status (ie, results of skin prick testing); however, family history of atopy was abstracted from the questionnaire. Although family history was strongly related to respiratory outcomes in univariate analysis, it was not significant in the statistical analysis performed when modeling with measures of foetal growth change. This is in keeping with the primary analysis of the RANOPS cohort which established that "prematurity-associated wheeze" phenotype is unlikely to include atopy as one of its determinants. 2 In our results, acceleration from the 2nd to 3rd trimester was statistically significantly associated with wheeze-ever.
This has not been widely reported in respiratory studies, although the latter Aberdeen study reported increased asthma with current wheeze for growth acceleration between the first and second trimesters, when compared to the reference category of consistently high growth. 12 Moreover, growth acceleration has been noted to be a risk factor for early adiposity gain at 6 months 33 and 3 years of age. 34 These potential adverse effects of both growth restraint and growth acceleration are consistent with the "predictive adaptive response," whereby altered fetal growth may dispose the infant to a developmental mismatch with the postnatal environment. 
| Postnatal weight gain in preterm-born children
Few studies in preterm-born cohorts have investigated the association between early weight gain in infancy and respiratory health in childhood and adolescence. A study of the NINFEA cohort demonstrated that rapid growth velocity was a significant predictor of increased wheeze during the first 18 months of life in term-born infants. 17 Two recent studies in term-born children reported TABLE 2 Associations between infant weight gain from birth to 9 months of age and respiratory outcomes in preterm-born children decrements in lung function and increased respiratory symptoms at age 5 when rapid postnatal growth was observed between birth and 3 months of age, the latter of which was independent of fetal growth. 14, 18 Both the Southampton and Aberdeen groups noted that early childhood wheeze at age 3 was statistically significantly associated with weight gain throughout the first year of life. 13, 35 The report by Belfort noted an association between asthma at the age of 8 years and postnatal growth in preterm infants. 36 This was not compensated by increased linear growth, indicating the potential developmental mismatch between somatic and organ growth which may promote later obesity and lung disease, possibly through the proinflammatory immunological effects. 37 Other studies in term-born cohorts have investigated longer periods over which to define weight gain and noted increased FIGURE 1 Graphical representation of interaction analysis (adjusted). All ORs for wheeze-ever are compared to the reference category of Term-born, no change in weight gain between birth and 9 months of age (* P < 0.05 compared to reference category). Error bars represent 95% confidence intervals for ORs FIGURE 2 Diagrammatic representation of mediation analysis results in preterm-born children respiratory infections in the first years of life, 16 asthma in school-age children, 19, 38 and decreased measures of peripheral airway flow in adolescence. 15 Along with our data in preterm-born children, these studies further support the concept that rate of weight gain is an important factor in influencing later respiratory health, possibly because the airways may be small in comparison to lung capacity (dysanapsis). Further data on lung function complement this hypothesis. 39 We repeated our analysis using weight data at 24 months, and failed to detect associations with respiratory symptoms (data not shown). Methodological differences in calculating weight gain may be responsible for these differences, however, one possibility is that the deleterious effects of early weight gain on respiratory health may be mitigated if "catch-up" lung growth occurs over a longer period of time.
Our previous data suggest that deficits in FEV 1 present in IUGR termborn children are ameliorated by catch-up growth by 8 years of age. 25 Similar to others, 20 we observed an incremental increase in odds of wheeze-ever for decreasing gestational age with infant weight gain, when compared to a term-born control growth without weight gain (OR 5.04).
We extended our findings by identifying current maternal smoking, as well as gestation, as a mediator of the relationship between weight gain and wheeze-ever in preterm-born children. Maternal smoking can be considered a proxy of socio-economic status and may represent higher rates of formula feeding. 40 Thus, nutrition may be key in balancing the beneficial effects of growth versus potential harm of excess weight gain in preterm-born infants. Exclusive breastfeeding ameliorated the association between postnatal weight gain and increased early transient wheeze in term-born children in the study by Turner et al. 32 
| Strengths and limitations
In common with many cohort studies, the main limitation of our work is the attrition of cases available for analysis due to non-response to the questionnaire survey, absence of consent for data linkage, and challenges with database accessibility. Moreover, we cannot rule out residual confounding in our data by unmeasured covariates. We conducted an additional sensitivity analysis by modeling wheeze-ever on the interaction between each variable in our final model with infant weight gain. The results indicated that weight gain may have a differential effect in certain sub-groups (eg, gender), Supplementary Table S7 . Another limitation of our study is its use of an exploratory approach to model-building and the lack of overall control for the multiplicity of hypothesis tests which involved multiple outcome variables, multiple definitions of the exposure variables, and multiple inclusion criteria (eg, subgroups). Thus, some results may have occurred by chance and this must be considered when interpreting the data. In the cohort at-large, non-responders to the questionnaire were of lower socio-economic status. 2 However, given that infants born into such conditions are more likely to be born preterm, IUGR and have been exposed to a less favorable intrauterine growth environment, we conjecture that inclusion of these children might have strengthened the associations we have observed.
The main strength of our study is the use of a contemporary cohort of preterm-born children for exploration of growth patterns and exposures that may be risk factors for wheezing symptoms in childhood. We used well-established, validated questionnaires; this allows comparison with other studies. Moreover, we were able to link to national databases to obtain both antenatal and postnatal measurements for the majority of the cohort who provided respiratory symptom data; however, we were limited to only routinely collected data. The sample sizes and numbers of non-missing values varied across the measured predictors and outcomes.
Some cases had valid fetal data only, whereas some had valid postnatal data only, and as such different cases were included in the two analyses.
Data were obtained retrospectively; we acknowledge that prospective collection of data may have improved the accuracy of the results and there will be some variation due to differences between equipment and use by the operator. Notwithstanding, we used two methods of defining weight gain and obtained similar results.
| CONCLUSION
In conclusion, our study suggests that antenatal and postnatal growth rates are important for future respiratory health in preterm-born children.
Since they are unlikely to have the same etiology of lung disease as their term-born peers, it is important to consider strategies for ensuring appropriate growth. Optimizing nutrition in the neonatal period and diminishing exposure to environmental pollutants, such as anti-andpostnatal tobacco smoking, present two potential interventions. 
